Jaw‐Ching Wu

6.0k total citations · 1 hit paper
102 papers, 4.8k citations indexed

About

Jaw‐Ching Wu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jaw‐Ching Wu has authored 102 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hepatology, 69 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Jaw‐Ching Wu's work include Liver Disease Diagnosis and Treatment (57 papers), Hepatocellular Carcinoma Treatment and Prognosis (43 papers) and Liver Disease and Transplantation (29 papers). Jaw‐Ching Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (57 papers), Hepatocellular Carcinoma Treatment and Prognosis (43 papers) and Liver Disease and Transplantation (29 papers). Jaw‐Ching Wu collaborates with scholars based in Taiwan, United States and United Kingdom. Jaw‐Ching Wu's co-authors include Teh‐Ia Huo, Chien‐Wei Su, Yi‐Hsiang Huang, Shou‐Dong Lee, Han‐Chieh Lin, Pui-Ching Lee, Gar-Yang Chau, Full-Young Chang, Shou‐Dong Lee and Fa‐Yauh Lee and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Jaw‐Ching Wu

99 papers receiving 4.7k citations

Hit Papers

MicroRNA-122 plays a critical role in liver homeostasis a... 2012 2026 2016 2021 2012 200 400 600

Peers

Jaw‐Ching Wu
Yong‐Han Paik South Korea
Jaw‐Ching Wu
Citations per year, relative to Jaw‐Ching Wu Jaw‐Ching Wu (= 1×) peers Yong‐Han Paik

Countries citing papers authored by Jaw‐Ching Wu

Since Specialization
Citations

This map shows the geographic impact of Jaw‐Ching Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaw‐Ching Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaw‐Ching Wu more than expected).

Fields of papers citing papers by Jaw‐Ching Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaw‐Ching Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaw‐Ching Wu. The network helps show where Jaw‐Ching Wu may publish in the future.

Co-authorship network of co-authors of Jaw‐Ching Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jaw‐Ching Wu. A scholar is included among the top collaborators of Jaw‐Ching Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaw‐Ching Wu. Jaw‐Ching Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiou, Yi‐You, Nai‐Chi Chiu, Chien-An Liu, et al.. (2020). Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation. Scientific Reports. 10(1). 2006–2006. 10 indexed citations
2.
Hsu, Wei‐Fan, et al.. (2019). Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study. Gastroenterology Research and Practice. 2019. 1–8. 12 indexed citations
3.
Chen, Po‐Chun, et al.. (2019). The correlation between fatty liver disease and chronic kidney disease. Journal of the Formosan Medical Association. 119(1). 42–50. 16 indexed citations
4.
Kao, Wei‐Yu, Yee Chao, Chun‐Chao Chang, et al.. (2015). Prognosis of Early-Stage Hepatocellular Carcinoma. Medicine. 94(43). e1929–e1929. 32 indexed citations
5.
Wu, Jaw‐Ching, Jin‐Wu Tsai, Lung‐Sen Kao, et al.. (2015). ENU mutagenesis identifies mice modeling Warburg Micro Syndrome with sensory axon degeneration caused by a deletion in Rab18. Experimental Neurology. 267. 143–151. 8 indexed citations
6.
Hung, Hung-Hsu, Yee Chao, Yi‐You Chiou, et al.. (2014). A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6. Medicine. 93(29). e348–e348. 15 indexed citations
7.
Wu, Jaw‐Ching, et al.. (2014). Baculovirus-Mediated miRNA Regulation to Suppress Hepatocellular Carcinoma Tumorigenicity and Metastasis. Molecular Therapy. 23(1). 79–88. 31 indexed citations
8.
Hung, Hung-Hsu, Hao-Jan Lei, Gar-Yang Chau, et al.. (2012). Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection. Journal of Gastrointestinal Surgery. 17(4). 702–711. 28 indexed citations
9.
Lan, Ming‐Ying, Chi‐Long Chen, Kuan‐Ting Lin, et al.. (2010). From NPC Therapeutic Target Identification to Potential Treatment Strategy. Molecular Cancer Therapeutics. 9(9). 2511–2523. 17 indexed citations
10.
Kao, Wei‐Yu, Hung-Hsu Hung, Han‐Chieh Lin, et al.. (2010). Hepatocellular Carcinoma With Presentation of Budd-Chiari Syndrome. Journal of the Chinese Medical Association. 73(2). 93–96. 4 indexed citations
11.
Huo, Teh‐Ia, Han‐Chieh Lin, Pui-Ching Lee, et al.. (2008). Comparison of four model for end-stage liver disease–based prognostic systems for cirrhosis. Liver Transplantation. 14(6). 837–844. 41 indexed citations
12.
Hsia, Cheng‐Yuan, Chi‐Jen Chu, Yi‐Hsiang Huang, et al.. (2007). The predictive ability of serum α‐fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Journal of Surgical Oncology. 95(8). 645–651. 10 indexed citations
13.
Lu, Sheng‐Nan, Wei‐Wen Su, Sheng‐Shun Yang, et al.. (2006). Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan. International Journal of Cancer. 119(8). 1946–1952. 111 indexed citations
14.
Huo, Teh‐Ia, Yi‐Hsiang Huang, Hui‐Chun Huang, et al.. (2006). Fever and Infectious Complications After Percutaneous Acetic Acid Injection Therapy for Hepatocellular Carcinoma: Incidence and Risk Factor Analysis. Journal of Clinical Gastroenterology. 40(7). 639–642. 6 indexed citations
16.
Huo, Teh‐Ia, Yi‐Hsiang Huang, & Jaw‐Ching Wu. (2005). Percutaneous Ablation Therapy for Hepatocellular Carcinoma: Current Practice and Future Perspectives. Journal of the Chinese Medical Association. 68(4). 155–159. 32 indexed citations
17.
Wu, Jaw‐Ching, Pui-Ching Lee, Yi‐Hsiang Huang, et al.. (2003). Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. European Journal of Gastroenterology & Hepatology. 15(11). 1203–1208. 29 indexed citations
18.
Huang, Yi‐Hsiang, Jaw‐Ching Wu, Wen‐Yung Sheng, et al.. (2000). Prevalence and risk factor analysis of TTV infection in prostitutes. Journal of Medical Virology. 60(4). 393–395. 13 indexed citations
19.
Wu, Jaw‐Ching, et al.. (1997). Specific inhibition of delta antigen by in vitro system by antisense oligodeoxynucleotide: implications for translation mechanism and treatment. Journal of Virological Methods. 65(2). 183–189. 11 indexed citations
20.
Lee, Shou‐Dong, et al.. (1987). Hepatitis B vaccination in healthy Chinese adults with low dose regimens. Vaccine. 5(3). 195–198. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026